The pro-inflammatory nature of this pathway is further substantiated in other vascular models: GITR deficiency diminishes P/E-selectin and ICAM-1 expression in ischemia-reperfusion injury, whereas GITR agonist treatment intensifies post-stroke inflammation and neural stem cell apoptosis (188). This evidence concerns the gene TNFRSF18 and ischemia reperfusion injury.